<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-KYSR0LVZ</identifier><date>2013</date><creator>Rotar, Žiga</creator><relation>documents/doc/K/URN_NBN_SI_doc-KYSR0LVZ_001.htm</relation><relation>documents/doc/K/URN_NBN_SI_doc-KYSR0LVZ_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KYSR0LVZ_001.txt</relation><format format_type="issue">4</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 293-298</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">30897881</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KYSR0LVZ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">biologics</subject><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="slv">revmatoidni artritis</subject><subject language_type_id="eng">rheumatoid arthritis</subject><subject language_type_id="slv">spondiloartritis</subject><subject language_type_id="eng">spondyloarthritis</subject><subject language_type_id="eng">vasculitis</subject><subject language_type_id="slv">vaskulitis</subject><title>Uporaba bioloških zdravil v revmatologiji</title><title>Use of biologic disease modifiying drugs in rheumatology</title></Record>